Please wait a minute...
Shopping Cart Email List Chinese
Advanced Search Fig/Tab
Protein & Cell

ISSN 1674-800X

ISSN 1674-8018(Online)

CN 11-5886/Q

Postal Subscription Code 80-984

2018 Impact Factor: 7.575

Featured Articles  |  Most Downloaded  |  Most Reading
Online Submission Subscribe to Our RSS Content Feed
Prot Cell    2013, Vol. 4 Issue (3) : 168-175    https://doi.org/10.1007/s13238-012-2109-3      PMID: 23483478
REVIEW
Expression regulation and function of NLRC5
Yikun Yao, Youcun Qian()
The Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
 Download: PDF(389 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

The NOD like receptors (NLRs), a class of intracellular receptors that respond to pathogen attack or cellular stress, have gained increasing attention. NLRC5, the largest member of the NLR protein family, has recently been identified as a critical regulator of immune responses. While NLRC5 is constitutively and widely expressed, it can be dramatically induced by interferons during pathogen infections. Both in vitro and in vivo studies have demonstrated that NLRC5 is a specifi c and master regulator of major mistocompatibility complex (MHC) class I genes as well as related genes involved in MHC class I antigen presentation. The expression of MHC class I genes is regulated by NLRC5 in coordination with the RFX components through an enhanceosome-dependent manner. And the involvement of NLRC5 in MHC class I mediated CD8+ T cell activation, proliferation and cytotoxicity is proved to be critical for host defense against intracellular bacterial infections. Nevertheless, the role of NLRC5 in innate immunity remains to be further explored. Here, we review the research advances on the structure, expression regulation and function of NLRC5.
Keywords NLR      NLRC5      MHC Class I     
Corresponding Author(s): Qian Youcun,Email:ycqian@sibs.ac.cn   
Issue Date: 01 March 2013
 Cite this article:   
Yikun Yao,Youcun Qian. Expression regulation and function of NLRC5[J]. Prot Cell, 2013, 4(3): 168-175.
 URL:  
https://academic.hep.com.cn/pac/EN/10.1007/s13238-012-2109-3
https://academic.hep.com.cn/pac/EN/Y2013/V4/I3/168
1 Allen, I.C., Wilson, J.E., Schneider, M., Lich, J.D., Roberts, R.A., Arthur, J.C., Woodford, R.M., Davis, B.K., Uronis, J.M., Herfarth, H.H., . (2012). NLRP12 suppresses colon infl ammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. Immunity 36, 742-754 .
doi: 10.1016/j.immuni.2012.03.012
2 Anand, P.K., Malireddi, R.K., Lukens, J.R., Vogel, P., Bertin, J., Lamkanfi, M., and Kanneganti, T.D. (2012). NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 488, 389-393 .
doi: 10.1038/nature11250
3 Benko, S., Magalhaes, J.G., Philpott, D.J., and Girardin, S.E. (2010). NLRC5 limits the activation of infl ammatory pathways. J Immunol 185, 1681-1691 .
doi: 10.4049/jimmunol.0903900
4 Biswas, A., Meissner, T.B., Kawai, T., and Kobayashi, K.S. (2012). Cutting edge: impaired MHC class I expression in mice deficient for nlrc5/class I transactivator. Immunol 189, 516-520 .
doi: 10.4049/jimmunol.1200064
5 Camacho-Carvajal, M.M. , Klingler, S., Schnappauf, F., Hake, S.B., and Steimle, V. (2004). Importance of class II transactivator leucinerich repeats for dominant-negative function and nucleo-cytoplasmic transport. Int Immunol 16, 65-75 .
doi: 10.1093/intimm/dxh010
6 Chang, C.H., Guerder, S., Hong, S.C., van Ewijk, W., and Flavell, R.A. (1996). Mice lacking the MHC class II transactivator (CIITA) show tissue-specifi c impairment of MHC class II expression. Immunity 4, 167-178 .
doi: 10.1016/S1074-7613(00)80681-0
7 Cui, J., Li, Y., Zhu, L., Liu, D., Songyang, Z., Wang, H.Y., and Wang, R.F. (2012). NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol 13, 387-395 .
doi: 10.1038/ni.2239
8 Cui, J., Zhu, L., Xia, X., Wang, H.Y., Legras, X., Hong, J., Ji, J., Shen, P., Zheng, S., Chen, Z.J., . (2010). NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141, 483-496 .
doi: 10.1016/j.cell.2010.03.040
9 Davis, B.K., Roberts, R.A., Huang, M.T., Willingham, S.B., Conti, B.J., Brickey, W.J., Barker, B.R., Kwan, M., Taxman, D.J., Accavitti-Loper, M.A., . (2011). Cutting Edge: NLRC5-Dependent Activation of the Infl ammasome. J Immunol 186, 1333-1337 .
doi: 10.4049/jimmunol.1003111
10 Eisenbarth, S.C., Will iams, A., Colegio, O.R., Meng, H., Strowig, T., Rongvaux, A., Henao-Mejia, J., Thaiss, C.A., Joly, S., Gonzalez, D.G., . (2012). NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484, 510-513 .
doi: 10.1038/nature11012
11 Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., Peaper, D.R., Bertin, J., Eisenbarth, S.C., Gordon, J.I., . (2011). NLRP6 infl ammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 .
doi: 10.1016/j.cell.2011.04.022
12 Gong, Y.N., and Shao, F. (2012). Sensing bacterial infections by NAIP receptors in NLRC4 inflammasome activation. Protein Cell 3, 98-105 .
doi: 10.1007/s13238-012-2028-3
13 Hake, S.B., Masternak, K., Kammerbauer, C., Janzen, C., Reith, W., and Steimle, V. (2000). CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol Cell Biol 20, 7716-7725 .
doi: 10.1128/MCB.20.20.7716-7725.2000
14 Jabrane-Ferrat, N., Ne krep, N., Tosi, G., Esserman, L., and Peterlin, B.M. (2003). MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators. Int Immunol 15, 467-475 .
doi: 10.1093/intimm/dxg048
15 Jiang, H., and Chess, L. (2000). The specifi c regulation of immune responses by CD8+ T cells restricted by the MHC class IB molecule, QA-1. Annu Rev Immunol 18, 185-216 .
doi: 10.1146/annurev.immunol.18.1.185
16 Jounai, N., Kobiyama, K., Shiina, M., Ogata, K., Ishii, K.J., and Takeshita, F. (2011). NLRP4 negatively regulates autophagic processes through an association with beclin1. J Immunol 186, 1646-1655 .
doi: 10.4049/jimmunol.1001654
17 Khare, S., Dorfleutner, A., Bryan, N.B., Yun, C., Radian, A.D., de Almeida, L., Rojanasakul, Y., and Stehlik, C. (2012). An NLRP7- containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 36, 464-476 .
doi: 10.1016/j.immuni.2012.02.001
18 Kobayashi, K.S., and v an den Elsen, P.J. (2012). NLRC5: a key regulator of MHC class I-dependent immune responses. Nat Rev Immunol 12, 813-820 .
doi: 10.1038/nri3339
19 Kuenzel, S., Till, A., Winkler, M., Hasler, R., Lipinski, S., Jung, S., Grotzinger, J., Fickenscher, H., Schreiber, S., and Rosenstiel, P. (2010). The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. Immunol 184, 1990-2000 .
doi: 10.4049/jimmunol.0900557
20 Kumar, H., Pandey, S., Zou, J., Kumagai, Y., Takahashi, K., Akira, S., and Kawai, T. (2011). NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections. Immunol 186, 994-1000 .
doi: 10.4049/jimmunol.1002094
21 Lamkanfi, M., and Kann eganti, T.D. (2012). Regulation of immune pathways by the NOD-like receptor NLRC5. Immunobiology 217, 13-16 .
doi: 10.1016/j.imbio.2011.08.011
22 LeibundGut-Landmann, S., Waldburger, J.M., Krawczyk, M., Otten, L.A., Suter, T., Fontana, A., Acha-Orbea, H., and Reith, W. (2004). Mini-review: specifi city and expression of CIITA, the master regulator of MHC class II genes. Eur J Immunol 34, 1513-1525 .
doi: 10.1002/eji.200424964
23 Levinsohn, J.L., Newman, Z.L., Hellmich, K.A., Fattah, R., Getz, M.A., Liu, S., Sastalla, I., Leppla, S.H., and Moayeri, M. (2012). Anthrax lethal factor cleavage of Nlrp1 is required for activation of the infl ammasome. PLoS Pathog 8, e1002638.
doi: 10.1371/journal.ppat.1002638
24 Lie, B.A., and Thorsby, E. (2005). Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr Opin Immunol 17, 526-531 .
doi: 10.1016/j.coi.2005.07.001
25 Martin, B.K., Chin, K. C., Olsen, J.C., Skinner, C.A., Dey, A., Ozato, K., and Ting, J.P.Y. (1997). Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6, 591-600 .
doi: 10.1016/S1074-7613(00)80347-7
26 Martinon, F., Mayor, A., and Tschopp, J. (2009). The infl ammasomes: guardians of the body. Annu Rev Immunol 27, 229-265 .
doi: 10.1146/annurev.immunol.021908.132715
27 Masternak, K., and Reith, W. (2002). Promoter-specifi c functions of CIITA and the MHC class II enhanceosome in transcriptional activation. Embo Journal 21, 1379-1388 .
doi: 10.1093/emboj/21.6.1379
28 Meissner, T.B., Li, A. , Biswas, A., Lee, K.H., Liu, Y.J., Bayir, E., Iliopoulos, D., van den Elsen, P.J., and Kobayashi, K.S. (2010). NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci U S A 107, 13794-13799 .
doi: 10.1073/pnas.1008684107
29 Meissner, T.B., Li, A. , Liu, Y.J., Gagnon, E., and Kobayashi, K.S. (2012a). The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity. Biochem Biophys Res Commun 418, 786-791 .
doi: 10.1016/j.bbrc.2012.01.104
30 Meissner, T.B., Liu, Y.J., Lee, K.H., Li, A., Biswas, A., van Eggermond, M.C., van den Elsen, P.J., and Kobayashi, K.S. (2012b). NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression. J Immunol 188, 4951-4958 .
doi: 10.4049/jimmunol.1103160
31 Moreno, C.S., Beresford, G.W., Louis-Plence, P., Morris, A.C., and Boss, J.M. (1999). CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10, 143-151 .
doi: 10.1016/S1074-7613(00)80015-1
32 Neerincx, A., Lautz, K., Menning, M., Kremmer, E., Zigrino, P., Hosel, M., Buning, H., Schwarzenbacher, R., and Kufer, T.A. (2010). A role for the human NLR family member NLRC5 in antiviral responses. J Biol Chem 285, 26223-26232 .
doi: 10.1074/jbc.M110.109736
33 Neerincx, A., Rodriguez, G.M., Steimle, V., and Kufer, T.A. (2012). NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. Immunol 188, 4940-4950 .
doi: 10.4049/jimmunol.1103136
34 Pamer, E., and Cresswell, P. (1998). Mechanisms of MHC class I- Restricted antigen processing. Ann Rev Immunol 16, 323-358 .
doi: 10.1146/annurev.immunol.16.1.323
35 Peaper, D.R., and Cresswell, P. (2008). Regulation of MHC Class I Assembly and Peptide Binding. Annu Rev Cell Dev Bi 24, 343-368 .
doi: 10.1146/annurev.cellbio.24.110707.175347
36 Robbins, G.R., Truax, A.D., Davis, B.K., Zhang, L., Brickey, W.J., and Ting, J.P. (2012). Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat containing (NLR) proteins. J Biol Chem 287, 24294-24303 .
doi: 10.1074/jbc.M112.364604
37 Savage, P.A., Boniface, J.J., and Davis, M.M. (1999). A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10, 485-492 .
doi: 10.1016/S1074-7613(00)80048-5
38 Schneider, M., Zimmermann, A.G., Roberts, R.A., Zhang, L., Swanson, K.V., Wen, H., Davis, B.K., Allen, I.C., Holl, E.K., Ye, Z., . (2012). The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modifi cation of the signaling adaptor TRAF6 and transcription factor NF-kappaB. Nat Immunol 13, 823-831 .
doi: 10.1038/ni.2378
39 Schroder, K., and Tsch opp, J. (2010). The infl ammasomes. Cell 140, 821-832 .
doi: 10.1016/j.cell.2010.01.040
40 Shepherd, J.C., Schumacher, T.N.M., Ashtonrickardt, P.G., Imaeda, S., Ploegh, H.L., Janeway, C.A., and Tonegawa, S. (1993). Tap1- Dependent Peptide Translocation in-Vitro Is Atp-Dependent and Peptide Selective. Cell 74, 577-584 .
doi: 10.1016/0092-8674(93)80058-M
41 Staehli, F., Ludigs, K., Heinz, L.X., Seguin-Estevez, Q., Ferrero, I., Braun, M., Schroder, K., Rebsamen, M., Tardivel, A., Mattmann, C., . (2012). NLRC5 defi ciency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells. Immunol 188, 3820-3828 .
doi: 10.4049/jimmunol.1102671
42 Strober, W., Murray, P.J., Kitani, A., and Watanabe, T. (2006). Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 6, 9-20 .
doi: 10.1038/nri1747
43 Tong, Y., Cui, J., Li, Q., Zou, J., Wang, H.Y., and Wang, R.F. (2012). Enhanced TLR-induced NF-kappaB signaling and type I interferon responses in NLRC5 defi cient mice. Cell Res 22, 822-835 .
doi: 10.1038/cr.2012.53
44 Tschopp, J., and Schroder, K. (2010). NLRP3 infl ammasome activa tion: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10, 210-215 .
doi: 10.1038/nri2725
45 Vesely, M.D., Kershaw, M.H., Schreiber, R.D., and Smyth, M.J. (2011). Natural innate and adaptive immunity to cancer. Annu Rev Immunol 29, 235-271 .
doi: 10.1146/annurev-immunol-031210-101324
46 Vladimer, G.I., Weng, D., Paquette, S.W., Vanaja, S.K., Rathinam, V.A., Aune, M.H., Conlon, J.E., Burbage, J.J., Proulx, M.K., Liu, Q., . (2012). The NLRP12 Infl ammasome Recognizes Yersinia pestis. Immunity 37, 96-107 .
doi: 10.1016/j.immuni.2012.07.006
47 Williams, G.S., Malin, M., Vremec, D., Chang, C.H., Boyd, R., Benoist, C., and Mathis, D. (1998). Mice lacking the transcription factor CIITA--a second look. Int Immunol 10, 1957-1967 .
doi: 10.1093/intimm/10.12.1957
48 Williams, K.L., Taxman, D.J., Linhoff, M.W., Reed, W., and Ting, J.P.Y. (2003). Cutting edge: Monarch-1: A pyrin/nucleotide-binding domain/leucine-rich repeat protein that controls classical and nonclassical MHC class I genes. Journal of Immunology 170, 5354-5358 .
49 Yao, Y., Wang, Y., Chen, F., Huang, Y., Zhu, S., Leng, Q., Wang, H., Shi, Y., and Qian, Y. (2012). NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens. Cell Res 22, 836-847 .
doi: 10.1038/cr.2012.56
50 Zaki, M.H., Vogel, P., Malireddi, R.K., Body-Malapel, M., Anand, P.K., Bertin, J., Green, D.R., Lamkanfi, M., and Kanneganti, T.D. (2011). The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20, 649-660 .
doi: 10.1016/j.ccr.2011.10.022
51 Zhao, Y., and Shao, F. (2012). NLRC5: a NOD-like receptor protein with many faces in immune regulation. Cell Res 22, 1099-1101 .
doi: 10.1038/cr.2012.83
[1] Chunju Fang,Xiawei Wei,Yuquan Wei. Mitochondrial DNA in the regulation of innate immune responses[J]. Protein Cell, 2016, 07(1): 11-16.
[2] Hua Li, Shuxian Wu, Liming Mao, Guowei Lei, Liping Zhang, Ailing Lu, Liguo An, Guiwen Yang, Paride Abliz, Guangxun Meng. Human pathogenic fungus Trichophytonschoenleinii activates the NLRP3 inflammasome[J]. Prot Cell, 2013, 4(7): 529-538.
[3] Yan Wang, Chen Yang, Kairui Mao, Shuzhen Chen, Guangxun Meng, Bing Sun. Cellular localization of NLRP3 inflammasome[J]. Prot Cell, 2013, 4(6): 425-431.
[4] Hongbin Wang, Yue Xing, Liming Mao, Yi Luo, Lishan Kang, Guangxun Meng. Pannexin-1 influences peritoneal cavity cell population but is not involved in NLRP3 inflammasome activation[J]. Prot Cell, 2013, 4(4): 259-265.
[5] Shuzhen Chen, Bing Sun. Negative regulation of NLRP3 inflammasome signaling[J]. Prot Cell, 2013, 4(4): 251-258.
[6] Yi-Nan Gong, Feng Shao. Sensing bacterial infections by NAIP receptors in NLRC4 inflammasome activation[J]. Prot Cell, 2012, 3(2): 98-105.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed